Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/31/10
End: 07/31/12
Due: 07/31/13
Phase: N/A
Priority: Normal
Start: 12/31/12
End: 07/31/14
Due: 07/31/15
Phase: N/A
Priority: Normal
Start: 08/31/14
End: 02/29/16
Due: 02/28/17
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Raltegravir Use as Nonoccupational Postexposure Prophylaxis (NPEP) in Men Who Have Sex With Men | NCT01087840 | Andrew Carr | user2@example.com | None | 2010-07-31 | 2012-07-31 | 2013-07-31 | - | - | 2025-07-14 |
| Safety, Tolerability,and Adherence to Co-formulated Tenofovir-emtricitabine-rilpivirine Used as HIV Nonoccupational Post-exposure Prophylaxis in Men Who Have Sex With Men. | NCT01715636 | Andrew Carr | user2@example.com | None | 2012-12-31 | 2014-07-31 | 2015-07-31 | - | - | 2025-07-14 |
| The Tolerability of, and Adherence to, Dolutegravir With Co-formulated Tenofovir-emtricitabine for HIV Non-occupational Post-exposure Prophylaxis | NCT02211690 | Andrew Carr | user2@example.com | None | 2014-08-31 | 2016-02-29 | 2017-02-28 | - | - | 2025-07-14 |